Impact of Complications on Resource Utilization During 90-Day Coronary Artery Bypass Graft Bundle for Medicare

Steven D Culler1, Phillip P Brown2, Aaron D Kugelmass3

  • 1Rollins School of Public Health, Emory University, Atlanta, Georgia.

Insights

Adverse events during coronary artery bypass graft surgery (CABG) significantly increase Medicare costs. Managing these complications is crucial for hospitals in bundled payment programs to mitigate financial risk.

Area of Science:

  • Health Economics
  • Cardiovascular Surgery
  • Healthcare Policy

Background:

  • Coronary artery bypass graft surgery (CABG) is a major cardiovascular procedure.
  • Understanding the financial implications of CABG is vital for healthcare providers and policymakers.

Purpose of the Study:

  • To analyze the impact of adverse events during CABG on Medicare reimbursement.
  • To quantify the additional costs associated with complications following CABG.

Main Methods:

  • Retrospective analysis of 2014 Medicare claims data.
  • Inclusion of 37,106 Medicare beneficiaries undergoing CABG.
  • Identification of adverse events including renal failure, infection, stroke, and reoperation.

Main Results:

  • Average total Medicare reimbursement for CABG and 90-day follow-up was $42,063.
  • Patients with adverse events incurred an average of $15,941 more in reimbursement.
  • New-onset hemodialysis, septicemia, stroke, and infection significantly increased costs by over $20,000.

Conclusions:

  • Adverse events during CABG substantially increase financial risk for hospitals.
  • Effective monitoring and reduction of adverse events are essential for the success of bundled payment programs.
  • Managing post-CABG care across all venues is critical for controlling costs.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687